In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Felix Hernandez Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Felix
Last Name:Hernandez
Title:Dr
Affiliation:LECTURER
Department:Molecular Biology
Street Address 1:UNIVERSIDAD aUTONOMA DE MADRID. CARRETERA DE cANTOBLANCO
City:Madrid
Zip/Postal Code:28049
Country/Territory:Spain
Phone:34 911964563
Fax:34 911964420
Email Address: 
Disclosure:
(view policy)  		 
View all comments by Felix Hernandez
Clinical Interests:
Alzheimer Disease, Tauopathies
Research Focus:
Oxidative Stress, A-beta PP/A-beta, Tau/Cytoskeleton
Work Sector(s):
University, Research institute
Web Sites:
Personal: http://www.uam.es/felix.hernandez
Professional: http://www.cbm.uam.es/mkfactory.esdomain/webs/CBMSO/plt_Home.aspx
Lab: http://www.cbm.uam.es/mkfactory.esdomain/webs/CBMSO/plt_LineasInvestigacion.aspx?IdObjeto=30
Top Papers
N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation.Goñi-Oliver P, Lucas JJ, Avila J, Hernández F.J Biol Chem. 2007 Aug 3;282(31):22406-13. Epub 2007 Jun 14. PMID: 17569662

Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.Engel T, Goñi-Oliver P, Lucas JJ, Avila J, Hernández F.J Neurochem. 2006 Dec;99(6):1445-55. Epub 2006 Oct 24.
PMID: 17059563

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.
Engel T, Hernández F, Avila J, Lucas JJ. J Neurosci. 2006 May 10;26(19):5083-90.
PMID: 16687499


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad